When Canada finally introduced the regulations that would allow edible and drinkable cannabis products in 2019, the industry was abuzz with excitement. A year after legalization, it seemed consumers would finally have access to infused snacks and beverages comparable to products found in legal states south of the border.

You'd struggle to find an industry that's generated more robust returns than cannabis in recent months. The ETFMG Alternative Harvest ETF, a basket fund that contains an assortment of direct and ancillary marijuana stocks, is up 212% since the end of October (through Feb. 10).

It wasn’t too long ago that if you asked somebody what CBD was, they would look at you with a puzzled expression on their face. Today, CBD is on everyone’s lips, dominating the conversation on medical cannabis and its therapeutic effects and being touted as a health supplement at nutrition stores. It can also be purchased online and found in department stores, drug stores, grocery stores, gas stations and, of course, dispensaries.

With CBD’s popularity comes a learning curve for the discerning consumer. In order to find the best product for their needs, consumers need to know the terminology around CBD products.

The rising tide of legal cannabis commerce is finally attracting the attention of so-called “Big Beer” corporations, and with good reason. Over the past seven years, home and craft brewers carved a niche for themselves by partnering with hemp farms and wholesale retailers with cannabis terpenes for sale to make infused beers — a novel and unique new line of products in a once oversaturated beer market.

Since 2017, Big Beer has slowly begun to test the waters of the infused beer space with the rollout of a number of tentative, experimental products.

From a global pandemic that disrupted nearly every market to a historic presidential election year, 2020 was unprecedented for the cannabis industry in almost every way. The year brought on new and market-altering challenges when it came to supply chain and statewide lockdowns. It also presented several opportunities to the industry after state governments deemed cannabis an essential business.

The best thing to do is to start with the basics. Gradually, you can move to more complex gear if you want to take your experience to the next level.

Concentrates are perhaps the trickiest form of cannabis you may come across. They are highly potent, and the consumption techniques are also complicated, whether you choose to smoke, vape, or dab. Still, using the right gear can make things a lot simpler for beginners, and you get better with practice and experience. The choice of equipment depends on several factors, which you need to consider when making your decision. Here are some helpful tips that you can follow while choosing the right gear for using concentrates.

Will These 3 Cannabis Stocks Give Investors More Market Value

Currently, in 2021, there has been more money invested in marijuana stocks and the industry as a whole. As the cannabis industry gears up for the potential of federal cannabis reform there is great excitement behind it. Because of this investors have been making sure they don’t miss a good opportunity. This positive sentiment has created some more upward momentum causing some marijuana stocks to reach new all-time highs.

As a dispensary builder, one of the most common questions we’re asked is: How much does it cost to build a cannabis dispensary? We usually answer that question with about 20 questions of our own, because no two cannabis retail stores are the same.

Even when we build dispensaries for national companies that specify the same design and finishes, we face unique circumstances in each state that affect overall project costs. Ultimately, that cost can range anywhere from $350,000 to $3.5 million.

Sales of marijuana concentrates shot up more than 40 percent last year and accounted for a larger share of the overall cannabis market, as consumers became more comfortable with the intricate process of dabbing and new technology has made the products easier to use.

In addition, some consumers are moving away from vape products because of respiratory-related health concerns and turning to concentrates such as wax, hash and shatter, according to industry insiders.

Aurora Cannabis Inc. said its second-quarter revenue came in flat from the prior period, while missing expectations as the company sold less legal pot in the Canadian recreational market. 

Aurora said that it generated $67.7 million in revenue in its fiscal second quarter, little changed from the prior three-month period, but up 23 per cent from last year. The Edmonton-based company said its sales in the Canadian recreational cannabis market fell 17 per cent from the prior quarter to $28.6 million while its medical cannabis revenue rose 16 per cent to $38.9 million. 

"We made some decisions in the quarter that impact on revenue," said Miguel Martin, chief executive officer at Aurora, in an interview.